Skip to main content
MOH
NYSE Life Sciences

Molina Healthcare Q1 Revenue Drops 4%, Adjusted EPS Plunges 61% on Membership Loss

feedReported by Reuters
Sentiment info
Negative
Importance info
8
Price
$155.51
Mkt Cap
$7.97B
52W Low
$121.06
52W High
$333.22
Market data snapshot near publication time

summarizeSummary

Molina Healthcare reported a significant decline in its first-quarter financial results, with premium revenue falling 4% year-over-year to $10.17 billion and adjusted EPS plunging 61% to $0.27. The revenue drop was primarily attributed to lower Medicaid and Marketplace membership, while profitability was further impacted by a $93 million impairment charge related to the planned exit of a Medicare Advantage-Part D product. Despite these weak Q1 figures, the company reaffirmed its full-year 2026 premium revenue and adjusted earnings guidance. Traders will closely monitor future membership trends and any potential revisions to the full-year outlook, especially given the substantial Q1 underperformance.

At the time of this announcement, MOH was trading at $155.51 on NYSE in the Life Sciences sector, with a market capitalization of approximately $8B. The 52-week trading range was $121.06 to $333.22. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


show_chartPrice Chart

Share this article

Copied!

feed MOH - Latest Insights

MOH
Apr 23, 2026, 10:11 AM EDT
Filing Type: 10-Q
Importance Score:
9
MOH
Apr 22, 2026, 4:28 PM EDT
Source: Reuters
Importance Score:
8
MOH
Apr 22, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
MOH
Mar 23, 2026, 4:18 PM EDT
Filing Type: DEF 14A
Importance Score:
8
MOH
Mar 13, 2026, 4:24 PM EDT
Filing Type: PRE 14A
Importance Score:
8
MOH
Feb 10, 2026, 4:18 PM EST
Filing Type: 10-K
Importance Score:
9
MOH
Feb 06, 2026, 5:06 PM EST
Filing Type: 8-K
Importance Score:
8
MOH
Feb 05, 2026, 4:20 PM EST
Filing Type: 8-K
Importance Score:
9